Journal Article

Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer

Brown, Patricia M. C., Nipp, Ryan D., Gaufberg, Eva, Temel, Jennifer S., Shulman, Eliza, El-Jawahri, Areej, Johnson, P. Connor, Qian, Carolyn L., Neckermann, Isabel, Greer, Joseph, Vyas, Charu, Hornstein, Shira B., Smith, Melissa, Reynolds, Mathew J.

2022

Overview

Background Patients with cancer often endure substantial symptoms and treatment toxicities leading to high healthcare utilization, including hospitalizations and emergency department visits, throughout the continuum of their illness. Innovative oncology care models are needed to improve patient outcomes and reduce their healthcare utilization. Using a novel hospital at home care platform, we developed a Supportive Oncology Care at Home intervention to address the needs of patients with cancer. Methods We are conducting three trials to delineate the role of Supportive Oncology Care at Home for patients with cancer. The Supportive Oncology Care at Home intervention includes: (1) a hospital at home care model for symptom assessment and management; (2) remote monitoring of daily patient-reported symptoms, vital signs, and body weight; and (3) structured communication with the oncology team. Our first study is a randomized controlled trial to test the efficacy of Supportive Oncology Care at Home versus standard oncology care for improving healthcare utilization, cancer treatment interruptions, and patient-reported outcomes in patients with cancer receiving definitive treatment of their cancer. Participants include adult patients with gastrointestinal and head and neck cancer, as well as lymphoma, receiving definitive treatment (e.g., treatment with curative intent). The second study is a single-arm trial assessing the feasibility and acceptability of the Supportive Oncology Care at Home intervention for hospitalized patients with advanced cancer. Eligible participants include adult patients with incurable cancer who are admitted with an unplanned hospitalization. The third study is a single-arm trial assessing the feasibility and acceptability of the Supportive Oncology Care at Home intervention to enhance the end-of-life care for patients with advanced hematologic malignancies. Eligible participants include adult patients with relapsed or refractory hematologic malignancy receiving palliative therapy or supportive care alone. Discussion These studies are approved by the Dana-Farber/Harvard Cancer Center Institutional Review Board and are being conducted in accordance with the Consolidated Standards of Reporting Trials statement for non-pharmacological trials. This work has the potential to transform the paradigm of care for patients with cancer by providing them with the necessary support at home to improve their health outcomes and care delivery. Trial registrations NCT04544046, NCT04637035, NCT04690205.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Adult / Biomedical and Life Sciences / Biomedicine / Blood cancer / Body weight / Cancer / Cancer Research / Cancer therapies / Care and treatment / Clinical outcomes / Clinical trials / Emergency medical care / Feasibility studies / Head & neck cancer / Head and Neck Neoplasms / Health care / Health Promotion and Disease Prevention / Health services utilization / Heart rate / Home care / Hospital at home care / Hospitalization / Humans / Intervention / Lymphoma / Malignancy / Medicine/Public Health / Methods / Oncology / Oncology care at home / Palliative Care - methods / Pancreatic cancer / Patient Reported Outcome Measures / Patients / Randomized Controlled Trials as Topic / Study Protocol / Supportive oncology care at home / Surgical Oncology / Symptom Assessment / Terminal Care - methods / Testing / Vital signs